Event Details
January 01, 2019
Description
UK Food Standards Agency (FSA) announced investigation of CBD products.
Participants (1)
| Name | Type | Mentions | |
|---|---|---|---|
| FSA | organization | 17 | View Entity |
Source Documents (1)
HOUSE_OVERSIGHT_024897.jpg
Market Research Report / Financial Analysis
• 2.09 MB
This document is page 81 of a Cowen Collaborative Insights market research report dated February 25, 2019, discussing the regulatory landscape for medical cannabis and CBD in Europe, specifically the UK and Italy. It details the legalization history, licensing requirements involving agencies like the MHRA and FSA, and market activities of companies like GW Pharmaceuticals, Tilray, Bedrocan, Canopy, and Aurora. The document bears a 'HOUSE_OVERSIGHT_024897' Bates stamp, indicating it was part of a document production for a House Oversight Committee investigation.
Event Metadata
Type
Unknown
Location
UK
Significance Score
5/10
Participants
1
Source Documents
1
Extracted
2025-11-19 22:39
Additional Data
Source
HOUSE_OVERSIGHT_024897.jpg
Date String
January 2019
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein event